Boardroom Alpha
Research library
SPACs · Oct 15, 2026

SPAC Market Update October 15, 2026: ATII-Forge Nano Vote, OACC Redemption Update

Archimedes Tech Spac Partners Ii Co (ATII) held its Forge Nano, Inc. merger vote on October 15, 2026; no transaction dollar value was disclosed. Forge Nano develops proprietary atomic layer deposition technology for semiconductor applications.

SPAC IPO Update — October 15, 2026

No SPAC IPOs priced on October 15, 2026; October MTD now stands at 3 IPOs totaling $385M over 15 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 3•Prior: 5•MoM: -2
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
3
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 3 IPOs ($385M) vs. first 15 days of last month 1 ($100M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 14 FLSC Frazier Life Sciences Acquisition Corp. II $75M 100.0%
Oct 06 PAXG PINE TREE ACQUISITION CORP $100M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 15, 2026

SPAC VOTE RESULTS
EVEREST CONSOLIDATOR ACQUISITION CORP (MNTN1) * Extend to December 31, 2027
ALPHA STAR ACQUISITION CORP (ALSAF) * Extend to December 15, 2027

MERGER VOTES
Archimedes Tech Spac Partners II Co (ATII) + FORGE NANO, INC.
Forge Nano, Inc. develops proprietary atomic layer deposition (ALD) technology for the semiconductor industry. It enables the conformal coating of 200mm wafers for various applications, including encapsulation, passivation, and dielectric coatings. The company collaborates with a range of commercial partners to provide tailored solutions, supporting both small-scale research and development as well as large-scale production.

SPAC EXTENSIONS
FUTURE VISION II ACQUISITION CORP (FVN) * Extension FilingSponsor funds a $65k extension; deadline to Nov 13, 2026, with note-to-unit conversion at $10 and forgiveness if no deal.

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-10-09: COPL + Ignite Proteomics Holdings,

OTHER SPAC NEWS
FORTUNEX ACQUISITION CORP (FXAC) * Merger Agreement AmendmentFortuneX, WT Realty, and Merger Sub amended the Business Combination Agreement to reduce Aggregate Merger Consideration to 52.5 million shares (implied $525M at $10/share); the total remains a fixed number of shares with no post-signing adjustments.
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC) * Redemption Update * 13,326,977 redeemedOaktree Acquisition III Life Sciences extends the extension. 13.33M Class A redeemed; sponsor converts B to A founder shares.
PIONEER ACQUISITION I CORP (PACH) * Merger Agreement

SPAC LISTING RULE NOTICES
PLUM ACQUISITION CORP IV (PLMK) * Listing Rule NoticeNasdaq deficiency for insufficient holders; 45-day plan to regain, potential 180-day extension; delisting not immediate.

SPAC DEALS ANNOUNCED
October 13 | Horizon Space Acquisition I Corp (HSPOF) + ArcheNova Biotech CorpArcheNova Biotech Corp is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of drugs derived from MSC-derived extracellular vesicles and exosomes. It is advancing five product candidates across various therapeutic areas, including dermatology, orthopedics, ophthalmology, neurology, and cardiology. Its lead candidate for psoriasis has completed a Phase I study and is preparing for a Phase II trial.

SPAC Movers — October 15, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
CALISA ACQUISITION CORP ALIS 7.8% $ 8.52 Announced
TCGX ACQUISITION CORP TCGX 4.2% $ 12.88 Pre-Deal
FUTURE VISION II ACQUISITION CORP FVN 3.8% $ 8.78 Announced
SILVERBOX CORP IV SBXD 2.6% $ 11.39 Announced
OAKTREE ACQUISITION CORP III LIFE SCIENCES OACC 1.7% $ 10.93 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
BLACK HAWK ACQUISITION CORP BKHA -38.0% $ 7.74 Announced
RF ACQUISITION CORP II RFAI -21.1% $ 30.05 Announced
RIBBON ACQUISITION CORP RIBB -8.2% $ 6.61 Announced
RISING DRAGON ACQUISITION CORP RDAC -7.0% $ 5.05 Announced
ARCHIMEDES TECH SPAC PARTNERS II CO ATII -6.1% $ 10.06 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • How many SPAC IPOs priced in October 2026 through October 15?
    3 SPAC IPOs priced for $385M through October 15, 2026, compared with 1 IPO for $100M over the same span in September 2026.
  • Which SPAC extension votes were approved on October 15, 2026?
    Everest Consolidator Acquisition Corp (MNTN1) won approval to extend to December 31, 2027, and Alpha Star Acquisition Corp (ALSAF) won approval to extend to December 15, 2027.
  • What target is tied to Alpha Star Acquisition Corp’s approved extension?
    Alpha Star Acquisition Corp (ALSAF) lists OU XDATA GROUP as the target tied to its approved extension vote.
  • What changed in FortuneX Acquisition Corp’s WT Realty merger agreement?
    FortuneX Acquisition Corp (FXAC), WT Realty and Merger Sub amended the business combination agreement to reduce aggregate merger consideration to a fixed share amount with no post-signing adjustments.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 15, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer